Chemours Co Stock: price and insider trades · United States · SEC (Form 4)

About Chemours Co

Chemours Co (ticker: CC) is a U.S.-listed chemical company traded on the NYSE in the United States (United States). The business was formed in 2015 through the spin-off of DuPont’s performance chemicals operations and began life as an independent public company. Its headquarters are in Wilmington, Delaware, giving Chemours a long-standing base in a major U.S. industrial hub. Today, the company positions itself as a global provider of performance chemicals, supported by a portfolio of well-known brands and leading positions in several specialized markets. ([chemours.com](https://www.chemours.com/en/news-media-center/all-news/press-releases/2015/the-chemours-company-completes-spin-off-from-dupont-and-launches-as-an-independent-publicly-traded-c?utm_source=openai)) Chemours is organized around three core segments: Thermal & Specialized Solutions (TSS), Titanium Technologies (TT), and Advanced Performance Materials (APM). TSS includes refrigerants and thermal-management solutions under the Opteon™ brand, serving air conditioning, industrial refrigeration, data centers, and broader energy-transition applications. TT is centered on titanium dioxide, marketed primarily through Ti-Pure™, a key input for paints, coatings, plastics, and paper. APM covers high-performance materials, including legacy brands such as Teflon™, Viton™, and Nafion™, with end markets spanning automotive, electronics, industrial processing, medical devices, and energy. This portfolio gives Chemours a mix of cyclical industrial exposure and more defensive specialty-chemistry franchises. ([chemours.com](https://www.chemours.com/en/about-chemours)) From a competitive standpoint, Chemours is better viewed as a specialty-chemicals platform than a pure commodity producer. Its value proposition is built on application expertise, customer-led product development, and trusted brands with strong market recognition. The company emphasizes its global reach and broad manufacturing footprint, which supports supply reliability and customer proximity. In 2025, performance remained uneven: TSS continued to show strong momentum, supported by growing adoption of Opteon™, while TT and APM faced softer demand in several cyclically sensitive end markets. A notable commercial highlight was the August 2025 qualification of Chemours’ two-phase immersion cooling fluid Opteon™ by Samsung Electronics, underlining the relevance of its advanced cooling technologies. At the same time, second-quarter 2025 results reflected litigation-related charges tied to the settlement announced with the State of New Jersey, reinforcing that legal and environmental liabilities remain an important part of the investment case. ([chemours.com](https://www.chemours.com/en/about-chemours)) For investors, Chemours combines specialty-chemistry upside, product innovation, and exposure to regulatory-driven refrigerant replacement opportunities. The offset is a meaningful risk profile: earnings are sensitive to titanium dioxide pricing, industrial demand cycles, and ongoing litigation and environmental issues. ([investors.chemours.com](https://investors.chemours.com/news-releases/news-release-details/chemours-company-reports-fourth-quarter-and-full-year-2025/?utm_source=openai))